Alterity Therapeutics clinical trials we track

Check company identity source

Phase 2 2 trials

TrialDrugs studiedStatusPrimary completion
A Biomarker Study of ATH434 in Participants With MSANCT05864365ATH434Completed2025-02-26Actual
Study of ATH434 in Participants with Multiple System AtrophyNCT05109091ATH434 dose level 1, ATH434 dose level 2Completed2024-11-28Actual

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.